Absci to Participate in the Piper Sandler Healthcare Conference
18 November 2022 - 12:00AM
Absci Corporation (Nasdaq: ABSI), a generative AI drug creation
company, today announced the company will be participating in the
upcoming Piper Sandler Healthcare Conference in New York, NY.
Absci management is scheduled to present on Thursday, December
1st at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). Interested
parties may access a live and archived webcast of the presentation
on the company’s investor relations website at:
investors.absci.com.
About Absci
Absci is the drug and target discovery company harnessing deep
learning AI and synthetic biology to expand the therapeutic
potential of proteins. We built our Integrated Drug Creation™
platform to identify novel drug targets, discover optimal
biotherapeutic candidates, and generate the cell lines to
manufacture them in a single efficient process. Biotech and pharma
innovators partner with us to create the next generation of
protein-based drugs, including Bionic™ proteins containing
nonstandard amino acids, and other novel drug designs that may be
impossible to make with other technologies. Our goal is to enable
the development of better medicines by Translating Ideas into
Drugs™. For more information visit www.absci.com and follow us on
social media: Twitter: @Abscibio, LinkedIn: @absci, and subscribe
to our Absci YouTube channel.
Availability of Other Information about
Absci
Investors and others should note that we routinely communicate
with investors and the public using our website (www.absci.com) and
our investor relations website (investors.absci.com), including
without limitation, through the posting of investor presentations,
SEC filings, press releases, public conference calls and webcasts
on these websites, as well as on Twitter, LinkedIn and YouTube. The
information that we post on these websites and social media outlets
could be deemed to be material information. As a result, investors,
the media, and others interested in Absci are encouraged to review
this information on a regular basis. The contents of our website
and social media postings, or any other website that may be
accessed from our website or social media postings, shall not be
deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended.
Investor Contactinvestors@absci.com
Media Contactpress@absci.com
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Apr 2023 to Apr 2024